Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Almonty Announces Intention to Relocate to the United States (click to learn more) Benton Intersects 22.0 m Grading 7.47% Copper Including 8.0 m Grading 11.93% Copper (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News OPTIMIZERx Corp OPRX

Technology Information Technology Services
OptimizeRx Corporation is a digital health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers diverse tech-enabled marketing solutions through its artificial intelligence (AI)-generated Dynamic Audience and Activation Platform (DAAP), which enables... see more

Recent & Breaking News (NDAQ:OPRX)

OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO

GlobeNewswire December 23, 2024

OptimizeRx to Participate in Upcoming Investor Conferences

GlobeNewswire November 18, 2024

OptimizeRx Reports Third Quarter 2024 Financial Results

GlobeNewswire November 13, 2024

OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET

GlobeNewswire October 31, 2024

OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value

GlobeNewswire September 10, 2024

OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences

GlobeNewswire September 9, 2024

OptimizeRx Reports Second Quarter 2024 Financial Results

GlobeNewswire August 8, 2024

OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET

GlobeNewswire July 25, 2024

OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation

GlobeNewswire July 23, 2024

OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients

GlobeNewswire July 15, 2024

New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations

GlobeNewswire June 20, 2024

OptimizeRx Reports First Quarter 2024 Financial Results

GlobeNewswire May 14, 2024

OptimizeRx to Participate in Upcoming Investor Conferences 

GlobeNewswire May 6, 2024

OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET

GlobeNewswire April 26, 2024

OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report

GlobeNewswire April 18, 2024

OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire April 16, 2024

OptimizeRx Named America's Fastest-Growing Company for Fifth Year in a Row

GlobeNewswire April 11, 2024

OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET

GlobeNewswire March 25, 2024

OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023

GlobeNewswire March 11, 2024

OptimizeRx Powers Walmart's 'Specialty Pharmacies of the Community' Outreach Effort

GlobeNewswire March 4, 2024